Blood tests for asbestos-related mesothelioma.
Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous exposure to asbestos. The incubation period of the tumor may be described as 30-40 years, and the prognosis is dismal. Recently, serum markers for the diagnosis of mesothelioma have been reported as candidates. In this paper, we mini-reviewed the potential utility of ELISA systems as serum diagnostic markers for asbestos-related mesothelioma.
Maeda
Masahiro
M
Immuno-Biological Laboratories Co., Ltd., Fujioka-Shi, Japan.
Hino
Okio
O
D001194:Asbestos / Q000633:toxicity*; D014408:Biomarkers, Tumor / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D002273:Carcinogens / Q000633:toxicity*; D004797:Enzyme-Linked Immunosorbent Assay; D058851:GPI-Linked Proteins; D006801:Humans; D008562:Membrane Glycoproteins / Q000097:blood*; D000090204:Mesothelin; D008654:Mesothelioma / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D015513:Oncogene Proteins / Q000097:blood*; D010997:Pleural Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000209:etiology
D014408:Biomarkers, Tumor; D001798:Blood Proteins; D002273:Carcinogens; C413325:Erc protein, human; D058851:GPI-Linked Proteins; D008562:Membrane Glycoproteins; D015513:Oncogene Proteins; D001194:Asbestos; D000090204:Mesothelin